Influence of endomorphins-1, 2 on glucose uptake by T and B lymphocytes in vivo

Cover Page

Cite item

Full Text

Abstract

The main method of treating pain syndrome is the use of morphine and its analogues, which have a wide range of side effects. In this regard, many modern studies are aimed at finding safer analgesic compounds. Currently, among morphine analogues, much attention is paid to endogenous opioid peptides, which, along with an analgesic effect, have pronounced immunoregulatory properties. It is now known that the functional activity of immune cells is ensured by metabolism. This process supplies cells with the energy necessary for activation, differentiation, proliferation, apoptosis, etc. Glucose metabolism plays a key role in ensuring the functions of immune cells. The aim of this work is to evaluate the effect of endomorphins-1, 2 on the characteristics of glucose uptake by T and B lymphocytes in vivo. The subjects of the study were white male mice, peptides were administered to mice intraperitoneally at a dose of 100 ìg/kg, and glucose uptake by cells was assessed using fluorescent analogues of glucose (2-NBDG). It was found that endomorphin-1 did not affect at the intensity of glucose consumption in both T and B cells. Administration of endomorphin-2, on the contrary, led to a significant increase in glucose uptake in T lymphocytes. However, the level of glucose consumption in B cells after administration of endomorphin-2 did not change significantly. In a study of two subsets of T lymphocytes, it was noted that endomorphin-2 leads to an increase in glucose uptake in both CD4+ and CD4-T cells. Administration of endomorphin-1 had no significant effect on the level of uptake of this substrate in both subsets of T lymphocytes. Proliferating B lymphocytes increased glucose consumption in the presence of LPS after administration of endomorphin-2. Both endomorphins did not have a significant effect on glucose consumption in proliferating CD4+ and CD4-T cells.

Thus, endomorphin-1, unlike endomorphin-2, does not have a significant effect on glucose metabolism in T and B cells. Taking into account the role of glycolysis in the functioning of immune cells and inflammation, it can be concluded that the use of endomorphin-1 may be associated with a lower risk of immune system-related side effects.

About the authors

S. V. Gein

Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center, Ural Branch, Russian Academy of Sciences; Perm State National Research University

Author for correspondence.
Email: gein@iegm.ru

PhD, MD (Medicine), Director; Professor, Department of Microbiology and Immunology

Russian Federation, Perm; Perm

Ya. A. Kadochnikova

Institute of Ecology and Genetics of Microorganisms, Perm Federal Research Center, Ural Branch, Russian Academy of Sciences

Email: gein@iegm.ru

Junior Research Associate, Laboratory of Molecular Immunology

Russian Federation, Perm

References

  1. Власова В.В., Шмагель К.В. Метаболические свойства Т-лимфоцитов и методы их регуляции (обзор) // Биохимия, 2023. T. 88, № 11, С.2251-2270. [Vlasova V.V., Shmagel K.V. T-lymphocyte metabolic features and techniques to modulate them (review). Biokhimiya = Biochemistry, 2023, Vol. 88, no. 11, pp. 2251-2270. (In Russ.)]
  2. Гейн С.В., Баева Т.А. Эндоморфины: структура, локализация, иммунорегуляторная активность // Проблемы эндокринологии, 2020. Т. 66, № 1. С. 78-86. [Gein S.V., Baeva T.A. Endomorphins: structure, localization, immunoregulatory activity. Problemy endokrinologii = Problems of Endocrinology, 2020, Vol. 66, no. 1, pp. 78-86. (In Russ.)]
  3. Гейн С.В., Кадочникова Я.А. Влияние эндоморфинов-1,2 на функциональную активность нейтрофилов и моноцитов периферической крови in vitro // Физиология человека, 2021. Т. 47, № 6. С. 65-71. [Gein S.V., Kadochnikova Y.A. Effect of endomorphins-1, 2 on functional activity of neutrophils and peripheral blood monocytes in vitro. Fiziologiya cheloveka = Human Physiology, 2021, Vol. 47, no. 6, pp. 646-651. (In Russ.)]
  4. Кадочникова Я.А., Гейн С.В. Влияние эндоморфинов на гуморальный иммунный ответ, продукцию Th1/Th2/Th17-цитокинов и апоптоз CD4+, CD8+ лимфоцитов in vivo // Медицинская иммунология, 2023. Т. 25, № 3. С. 545-550. [Kadochnikova Y.A., Gein S.V. Effect of endomorphins on humoral immune response, TH1/TH2/TH17 cytokine production and CD4+, CD8+ lymphocyte apoptosis in vivo. Meditsinskaya immunologiya = Medical Immunology (Russia), 2023, Vol. 25, no. 3. pp. 545-550. (In Russ.)] doi: 10.15789/1563-0625-EOE-2783.
  5. Bodnar R.J. Endogenous opiates and behavior. Peptides, 2010, Vol. 31, pp. 2325-2359.
  6. Horvath G. Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous -opioid receptor agonists. Pharmacol Ther., 2000, Vol. 88, no. 3, pp. 437-463.
  7. Janecka A., Staniszewska R., Fichna J. Endomorphin analogs. Curr. Med. Chem., 2007, Vol. 14, № 30, pp. 3201-3208.
  8. Keresztes A., Borics A., Tóth G. Recent advances in endomorphin engineering. Chem. Med. Chem., 2010, Vol. 5, no. 8, pp. 1176-1196.
  9. Kimmey B.A., McCall N.M., Wooldridge L.M., Satterthwaite T.D., Corder G. Engaging endogenous opioid circuits in pain affective processes. J. Neurosci. Res., 2022, Voil. 100, no. 1, pp. 66-98.
  10. Liu X., Wang Y., Xing Y., Yu J., Ji H., Kai M., Wang Z., Wang D., Zhang Y., Zhao D., Wang R. Design, synthesis, and pharmacological characterization of novel endomorphin-1 analogues as extremely potent -opioid agonists. Journal of Medicinal Chemistry, 2013, Vol. 56, no. 7, pp. 3102-3114.
  11. Ofoegbu A., Ettienne E.B. Pharmacogenomics and morphine. J. Clin. Pharmacol., 2021, Vol. 61, no. 9, pp. 1149-1155.
  12. Plein L.M., Rittner H.L. Opioids and the immune system – friend or foe. Br. J. Pharmacol., 2017, Vol. 175, no. 14, pp. 2717-2725.
  13. Pomorska D.K., Gach K., Janecka A. Immunomodulatory effects of endogenous and synthetic peptides activating opioid receptors. Med. Chem., 2014, Vol. 14, pp. 1148-1155.
  14. Rivero G., Llorente J., McPherson J., Cooke A., Mundell S.J., McArdle C.A., Rosethorne E.M., Charlton S.J., Krasel C., Bailey C.P., Henderson G., Kelly E. Endomorphin-2: A biased agonist at the -opioid receptor. Mol. Pharmacol., 2012, Vol. 82, no. 2, pp. 178-188.
  15. Zadina J.E., Nilges M.R., Morgenweck J., Zhang X., Hackler L., Fasold M.B. Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation. Neuropharmacology, 2016, Vol. 105, pp. 215-227.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Figure 1. Effect of endomorphins-1, 2 on glucose uptake in populations of mouse T lymphocytes (A) and B lymphocytes (B)

Download (123KB)
Indexing metadata
3. Figure 2. Effect of endomorphins-1, 2 on glucose uptake by mouse CD4+ (A) and CD4-T lymphocytes (B)

Download (126KB)
Indexing metadata
4. Figure 3. Effect of endomorphins-1, 2 on glucose uptake in T lymphocytes stimulated with Con A (A) and B lymphocytes stimulated with LPS (B)

Download (131KB)
Indexing metadata
5. Figure 4. Effect of endomorphins-1, 2 on glucose uptake by Con A stimulated mouse CD4+ (A) and CD4-T lymphocytes (B)

Download (139KB)
Indexing metadata

Copyright (c) 2024 Gein S.V., Kadochnikova Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies